Company profile
Kura Oncology, Inc. Insider Trading
KURAEvery SEC Form 4 insider trading filing for Kura Oncology, Inc. (KURA) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001422143
- Filings
- 98
- Insiders
- 15
- Last filing
- 2026-08-19
Activity summary
Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares (net $1.1M). Buying was led by Wilson Troy Edward.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Kura Oncology, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $2.2M.
90 day insight
Over the last 90 days, Kura Oncology, Inc. insiders bought $1.1M across 8 transactions with no open-market sales.
- Most active insider: Wilson Troy Edward with 1 transaction totaling $1.1M.
- Largest single purchase: $1.1M by Wilson Troy Edward on Aug 17, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Bair Teresa Brophy | KURA | Sale10b5 | 31,487 | $12.63 | $398K |
| Aug 17, 2026 | Wilson Troy Edward | KURA | Purchase | 100,000 | $11.12 | $1.11M |
| Jun 18, 2026 | Leoni Mollie | KURA | Sale10b5 | 84,929 | $9.82 | $834K |
| Jun 4, 2026 | Malley Thomas | KURA | Award | 35,000 | — | — |
| Jun 4, 2026 | Parks Diane L. | KURA | Award | 35,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=KURA" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Kura Oncology, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →